OncoTarget, ‎1949-2553

Journal

Publications

  1. 2020
  2. Published

    Paradox breaker BRAF inhibitors have comparable potency and MAPK pathway reactivation to encorafenib in BRAF mutant colorectal cancer

    Oliver Pickles, , , Andrew Beggs & Gary Middleton, 25 Aug 2020, In: OncoTarget. 11, 34, p. 3188-3197 10 p.

    Research output: Contribution to journalArticlepeer-review

  3. 2019
  4. Published
  5. 2018
  6. Published

    MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome

    Rachel Bayley, & Paloma Garcia, 1 Dec 2018, In: OncoTarget. 9, 101, p. 37460-37461 2 p.

    Research output: Contribution to journalEditorialpeer-review

  7. Published
  8. Published
  9. Published
  10. Published
  11. 2017
  12. Published

    Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours

    Susanne Gatz & 4 others, , , & , 6 Dec 2017, In: OncoTarget. 8, 67, p. 112036-112050 15 p.

    Research output: Contribution to journalArticlepeer-review

  13. Published

    ULBPs: regulators of human lymphocyte stress recognition

    Jianmin Zuo, Benjamin Willcox & Paul Moss, 13 Nov 2017, In: OncoTarget.

    Research output: Contribution to journalEditorialpeer-review

  14. Published
Previous 1 2 3 4 Next